Blue Capital Inc’s Merck MRK Stock Holding History

Blue Capital Inc’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279K	Hold	2,171	–	–	0.18%	101
2026 Q1	$261K	Hold	2,171	–	–	0.17%	92
2025 Q4	$229K	Buy	+2,171	New	+$204K	0.16%	81
2024 Q4	$208K	Buy	+2,087	New	+$215K	0.15%	106

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Blue Capital Inc's MRK Position: Q2 2026 in Review

Blue Capital Inc held its Merck (MRK) position steady in Q2 2026 at 2,171 shares worth $279K. The position accounts for 0.18% of the portfolio, ranked #101.

Blue Capital Inc first reported a position in MRK in Q4 2024 and has held it in 4 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Blue Capital Inc held 2,171 shares of Merck worth $279K as of Q2 2026.
Blue Capital Inc left its Merck share count unchanged in Q2 2026.
Merck made up 0.18% of Blue Capital Inc's portfolio in Q2 2026, its #101 holding.
Blue Capital Inc first reported a position in Merck in Q4 2024 and has held it in 4 quarters since.
3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Blue Capital Inc's 13F filing for Q2 2026, filed 11 Aug 2026.